Navigation Links
Mentice VIST(TM) New and Enhanced Carotid and Coronary Training Modules Take Medical Simulation Training to the Next Level
Date:12/1/2008

GOTHENBURG, Sweden, December 1 /PRNewswire/ -- Mentice proudly announces the launch of two new products for endovascular simulation training - the Mentice VIST 7.7 enhanced training modules for Carotid and Coronary interventions. New features such as vital signs, complications, medication management and measurement functionality add to the clinical realism and enhance the educational value of simulation training.

"Features like vital signs and complications imply a dynamic patient representation which requires further decision making, planning and patient interactions," said Goran Malmberg, President/CEO of Mentice.

"On top of the new functionalities, we are launching new anatomical content and further training alternatives such as CTO (Chronic Total Occlusion) lesions and cases that enable transradial access," Malmberg continues. "This launch truly shows that Mentice continues to be a driver of the medical simulation market and it further strengthens our position as a leader in the field of endovascular simulation training."

With the launch of the VIST 7.7 training modules Mentice adds to the already wide range of training opportunities for Carotid and Coronary interventions - all together a total of 42 patient cases. A summary of the new features are presented below.

Vital signs - All cases have vital signs recognition and response.

Complications - A select number of cases include complications that will occur as a result of user actions. One example, engaging a catheter too deeply into an ostium may result in vascular spasm.

Medication management - Medication administration is included to manage the complications the trainees encounter. One example of this would be the injection of Nitroglycerin for treatment of a spasm.

Measurement functionality - New measurement functionality has been added to allow the users to easily measure the diameters and length of lesions, reference vessels, etc - adding additional realism to the equipment selection process.

Mentice - improving patient safety

Mentice is a world leader in medical simulation, providing qualified solutions for training, education and assessment opportunities. With a focus on minimally invasive techniques and procedures, Mentice develops simulation systems for training in a safe environment within the fields of endovascular intervention and endoscopic surgery. The advantages of training with Mentice solutions are well documented enhancing clinical performance, reducing cost, and, in the long term, improving patient safety.

    For further information, please contact
    Goran Malmberg, President/CEO of Mentice.
    Office: +46-31-33-99-401,
    Web:http://www.mentice.com


'/>"/>
SOURCE Mentice AB
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mentice, Inc. Announces Appointment of Vice-President, Sales and Marketing, Americas
2. Mentice, Inc. Expands Its North American Sales and Clinical Presence With the Hiring of Jeff Sirek as Director of Educational Sales-East and Sue Landsman as Clinical Applications Manager for the Americas.
3. EDAP Launches Enhanced Communication Plans at SIU Paris Congress
4. Enhanced PrecyseCode 2X(TM) Further Accelerates Remote Coding and Improves Cash Flow for Hospitals
5. Joint Juice Launches New Ready-to-Drink Glucosamine & Vitamin-Enhanced Dietary Supplement Water Nationwide
6. The American Pain Foundation (APF) and The HealthCentral Network Collaborate to Develop Enhanced Internet Resources for People with Pain
7. PreViser Launches New Website and Enhanced Version of Its Oral Disease and Risk Assessment Software
8. NHP Reports Third Quarter 2007 Revenue and FFO Growth and Enhanced Disclosure Information
9. Brookdale Senior Living Announces Enhanced Web Site
10. T cell immunity enhanced by timing of interleukin-7 therapy
11. The HealthCentral Network and Sister to Sister Form Alliance to Develop Enhanced Online Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... ... February 06, 2016 , ... ... EXPECTED AT AORN SURGICAL CONFERENCE & EXPO , WHAT:     , This conference ... estimated 5000 perioperative nurses in attendance to study the latest evidence-based recommendations ...
(Date:2/6/2016)... ... ... Shark Finds and Kevin Harrington, along with the Product Managers ... Belly Bands. , Having a dog is great—except when it wets every couch, bed, ... works, get Belly Bands, the easiest way to stop dogs from wetting on ...
(Date:2/5/2016)... NY (PRWEB) , ... February 05, 2016 , ... Love ... long-stem roses in a variety of colors, assortments and packaging. This staple for Valentine’s ... any King Kullen location. , For Valentine’s Day, not only are long-stem roses ...
(Date:2/5/2016)... ... February 05, 2016 , ... Successful recruitment ... new clinical and scientific initiatives have all marked the last 12 months at ... and CEO of the nation’s oldest cancer center, Candace S. Johnson, PhD, outlined ...
(Date:2/5/2016)... ... February 05, 2016 , ... Francisco Canales, MD and ... their Napa Valley office. The technique utilizes the body’s own healing abilities to ... Dr. Furnas, are part of only a select few cosmetic surgeons bringing this ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016   Bernstein Liebhard LLP ... filed in the United States District Court for the District ... class (the "Class") consisting of all persons or entities who ... "Company") (NASDAQ: INSY ) from March 3, 2015 through ... and certain of its officers with violations of the Securities ...
(Date:2/4/2016)... Feb. 4, 2016 Summary Breast cancer, ... and the most common cancer in women worldwide, accounting ... exceedingly prevalent. The number of women diagnosed with breast ... the number of deaths has declined due to earlier ... has been revolutionized in the past four decades, especially ...
(Date:2/4/2016)... Feb. 4, 2016 Mettler-Toledo International Inc. (NYSE: ... 2015.  Provided below are the highlights: , ... compared with the prior year.  Reported sales decreased 3% ... quarter. , Net earnings per diluted share as ... prior- year period.  Adjusted EPS was $4.65, an increase ...
Breaking Medicine Technology: